Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23095009
Abstract: Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in… read more here.
Keywords: promises challenges; camelid single; domain antibodies; challenges lifesaving ... See more keywords